Argentina demands that Iran follow up on Jewish center bombing inquiry
President Fernández de Kirchner publicly asks Tehran government to keep its commitment


Argentinean President Cristina Fernández de Kirchner on Tuesday night called on Iran to follow through with a signed agreement in which the Tehran government committed itself to assisting an investigation into the 1994 bombing of a Jewish center in Buenos Aires — an attack that left 85 people dead and dozens injured.
Fernández de Kirchner used her address before the UN General Assembly to publicly ask Iran whether its parliament has actually approved the memorandum of understanding signed by both governments on January 27. This accord produced a fierce backlash from opposition groups and the Jewish community in Argentina, who accused the Fernández de Kirchner government of negotiating with a nation that has been internationally isolated because of its nuclear research program.
If there are Iranians implicated, the only one I can speak with is Iran"
Argentinean prosecutors have concluded that at least five top Iranian officials at their embassy in Buenos Aires were involved in organizing the blast that took place at the AMIA center. The five returned to Iran and have not made themselves available to Argentinean prosecutors.
“The case has been blocked for 19 years, and if there are five Iranians who are implicated, the only one that I can speak with so that a judge can take their testimony is Iran,” the president said.
“It is obvious but in this special world — and my country is also special — there are obvious things that must be explained.”
It was the first time that the Argentinean leader had publicly demanded that Iran take positive steps in the case. Over the past nine months, the government in Tehran has said that it was awaiting approval from its parliament.
Fernández de Kirchner said that she hoped that a fresh dialogue would begin with the new Iranian President Hassan Rowhani. “The president of France mentioned the nuclear case as something that is important for Iran. I want to mention the AMIA case.
“Now I hope that they tell us if they approved the accord or when are they going to approve it. We want answers and I think that sufficient time has passed.”
Tu suscripción se está usando en otro dispositivo
¿Quieres añadir otro usuario a tu suscripción?
Si continúas leyendo en este dispositivo, no se podrá leer en el otro.
FlechaTu suscripción se está usando en otro dispositivo y solo puedes acceder a EL PAÍS desde un dispositivo a la vez.
Si quieres compartir tu cuenta, cambia tu suscripción a la modalidad Premium, así podrás añadir otro usuario. Cada uno accederá con su propia cuenta de email, lo que os permitirá personalizar vuestra experiencia en EL PAÍS.
¿Tienes una suscripción de empresa? Accede aquí para contratar más cuentas.
En el caso de no saber quién está usando tu cuenta, te recomendamos cambiar tu contraseña aquí.
Si decides continuar compartiendo tu cuenta, este mensaje se mostrará en tu dispositivo y en el de la otra persona que está usando tu cuenta de forma indefinida, afectando a tu experiencia de lectura. Puedes consultar aquí los términos y condiciones de la suscripción digital.
Últimas noticias
More than 40 Democratic lawmakers urge Trump in a letter to stop his ‘attempts to undermine democracy in Brazil’
The journal ‘Science’ criticizes Trump’s anti-renewable energy policy: ‘The US is failing to benefit from its own innovations’
Cubans hope for a miracle as dengue and chikungunya spread
The long shadow of the father figure in the films of Rob Reiner
Most viewed
- Christian Louboutin: ‘Young people don’t want to be like their parents. And if their parents wear sneakers, they’re going to look for something else’
- Cartels in Mexico take a leap forward with narco-drones: ‘It is criminal groups that are leading the innovation race’
- ‘El Limones’ and the growing union disguise of Mexican organized crime
- The low-cost creative revolution: How technology is making art accessible to everyone
- ‘We are dying’: Cuba sinks into a health crisis amid medicine shortages and misdiagnosis








































